News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioRx Affirms Strong Supply of C1 Esterase Inhibitor Product


5/10/2012 10:39:28 AM

CINCINNATI--(BUSINESS WIRE)--In response to reports of a shortage of one C1 esterase inhibitor (C1-INH) product on the market, BioRx affirmed today that its supply of Berinert® (C1 esterase inhibitor, human) remains strong and can immediately accommodate increased demand. The statement was in response to publicly reported production delays affecting the only other commercially available C1-INH product. C1-INH products are FDA-approved for the treatment of hereditary angioedema (HAE).

Read at BioSpace.com


comments powered by Disqus
BioRx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES